Anavex Life Sciences
AVXL
#4611
Rank
$0.92 B
Marketcap
$11.85
Share price
1.72%
Change (1 day)
-39.39%
Change (1 year)

P/E ratio for Anavex Life Sciences (AVXL)

P/E ratio as of August 2022 (TTM): -21.6

According to Anavex Life Sciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -21.5741. At the end of 2021 the company had a P/E ratio of -33.0.

P/E ratio history for Anavex Life Sciences from 2007 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-33.0217.31%
2020-10.482.34%
2019-5.70-13.78%
2018-6.62-47.27%
2017-12.540.51%
2016-8.939.5%
2015-8.151178.17%
2014-0.6379-88.22%
2013-5.4284.8%
2012-2.93-43.33%
2011-5.17-46.31%
2010-9.632.01%
2009-9.4413.33%
2008-8.33-82.13%
2007-46.6

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.